APA (7th ed.) Citation

Afghan, M. K., Lutfi, A., Qadri, F., Khan, S., Javaid, S., Currie, B. M., . . . Kasi, P. M. (2024). Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization. Case Reports in Oncology, 17(1), 1183. https://doi.org/10.1159/000541550

Chicago Style (17th ed.) Citation

Afghan, Maaz Khan, et al. "Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization." Case Reports in Oncology 17, no. 1 (2024): 1183. https://doi.org/10.1159/000541550.

MLA (9th ed.) Citation

Afghan, Maaz Khan, et al. "Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization." Case Reports in Oncology, vol. 17, no. 1, 2024, p. 1183, https://doi.org/10.1159/000541550.